Foley Partner Andrew Rawlins was quoted in an article titled "BMS Sells ConvaTec: Are More Private Equity Deals on the Way?" in the May issue of MX Magazine. Rawlins gave his insight into private equity deals in the medtech industry. The article examined the recent trend of private equity firms acquiring large medtech companies valued at $500 million and greater and noted an expected slowdown in such deals as the current credit squeeze begins to affect the medtech industry.